Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.63
0.05 (3.16%)
At close: Aug 15, 2025, 3:59 PM
1.55
-4.62%
After-hours: Aug 15, 2025, 04:03 PM EDT
Mangoceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Cash & Equivalents | 76.5K | 58.65K | 73.91K | 490.24K | 15.3K | 739.01K | 1.24M | 2.95M | 3.79M | 682.86K | 873.49K | 868.00 | -22.55K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 45.1K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | 16.94K | 16.94K | 16.94K | 16.94K | 16.94K | 16.94K | 16.94K | 16.94K | n/a | -22.55K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | 13.21K | 14.02K | 14.45K | 18.5K | 21.58K | 23.49K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 100.16K | n/a | 16.94K | 13.3K | n/a | n/a | n/a | n/a | 31.27K | n/a | n/a | n/a | n/a |
Total Current Assets | 176.65K | 75.59K | 104.07K | 517.56K | 89.81K | 818.46K | 1.34M | 3.02M | 3.82M | 694.61K | 894.27K | 868.00 | 22.55K |
Property-Plant & Equipment | 46.33K | 62.3K | 77.97K | 93.32K | 194.7K | 215.39K | 235.85K | 255.87K | 275.85K | 291.74K | 2.53K | n/a | n/a |
Goodwill & Intangibles | 21.53M | 15.23M | 14.61M | 14.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 21.58M | 15.29M | 14.69M | 14.72M | 211.64K | 232.33K | 252.79K | 272.81K | 292.79K | 308.68K | 19.47K | n/a | -22.55K |
Total Assets | 21.75M | 15.37M | 14.79M | 15.24M | 301.45K | 1.05M | 1.6M | 3.3M | 4.12M | 1M | 913.74K | 868.00 | n/a |
Account Payables | n/a | 837.5K | 753.96K | 718.65K | 1.05M | 140.76K | 89.06K | 130.2K | 30.8K | 33.67K | n/a | 25K | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 47.71K | 150K | 187.5K | 187.5K | 87.5K | n/a | n/a | n/a | 89.2K | 167.46K | 89.2K | 114.2K | n/a |
Other Current Liabilities | 1.46M | 373K | 375K | 337.26K | n/a | -57.12K | 8.2K | n/a | -54K | n/a | n/a | n/a | n/a |
Total Current Liabilities | 1.5M | 1.43M | 1.39M | 1.38M | 1.21M | 211.08K | 159.18K | 196.48K | 182.84K | 260.58K | 89.87K | 139.2K | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | 12.17K | 30.12K | 47.71K | 64.96K | 81.51K | 97.39K | 113.27K | 128.68K | n/a | n/a | n/a |
Total Liabilities | 1.5M | 1.43M | 1.4M | 1.41M | 1.26M | 276.04K | 240.68K | 293.87K | 296.11K | 389.26K | 89.87K | 139.2K | 16.72K |
Total Debt | 47.71K | 214.96K | 269.01K | 285.05K | 200.77K | 128.68K | 143.43K | 157.54K | 260.89K | 352.87K | 89.2K | 114.2K | n/a |
Common Stock | 715.00 | 325.00 | 213.00 | 2.91K | 2.36K | 2.14K | 1.68K | 1.67K | 1.53K | 1.34K | 1.2K | 1.02K | n/a |
Retained Earnings | -25.94M | -20.81M | -17.99M | -15.99M | -13.6M | -11.23M | -8.66M | -6.86M | -4.58M | -2.02M | -1.34M | -366.79K | n/a |
Comprehensive Income | -2.22K | -9.85K | -1.66K | -1.17K | -70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.72K |
Shareholders Equity | 20.25M | 13.95M | 13.39M | 13.83M | -958.43K | 774.75K | 1.35M | 3M | 3.82M | 614.03K | 823.87K | -138.33K | -16.72K |
Total Investments | n/a | n/a | n/a | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 45.1K |